Cresset Biomolecular Discovery Ltd forms a lead-finding collaboration with Pharmagene

04-Mar-2005

Cresset BioMolecular Discovery Ltd (Cresset BMD) has announced that it has entered into a collaboration to find novel leads against one of Pharmagene's new drug discovery targets. Cresset will use its proprietary computational Field technology to generate electrostatic and surface-property molecular Fields for known active compounds against Pharmagene's target and use these to create templates to identify novel, diverse series of active compounds with drug-like characteristics.

Financial details of the collaboration were not disclosed.

Other news from the department business & finance

Most read news

More news from our other portals

So close that even
molecules turn red...